Insider · CIK 0001492647
June Sherie Almenoff
Files at TENX (TENAX THERAPEUTICS, INC.), ATNM (Actinium Pharmaceuticals, Inc.), AVTX (Avalo Therapeutics, Inc.). First filing Nov 14, 2024, latest Nov 14, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AVTX: Avalo Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | AGrant or award Common Stock10b5-1 | +18,000 | $0.00 | $0 | 18,000 | 38 d ago |
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +27,000 | $0.00 | $0 | 27,000 | 38 d ago |
| Jul 1, 2025 | TENX TENAX THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Jul 3, 2025 |
| Jun 17, 2025 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,100 | $0.00 | $0 | 20,100 | Jun 18, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Common Stock | +3,167 | - | - | 3,167 | Apr 1, 2025 |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,167 | $0.00 | $0 | 6,333 | Apr 1, 2025 |
| Dec 10, 2024 | TENX TENAX THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Dec 12, 2024 |
| Nov 12, 2024 | AVTX Avalo Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Meadowlark Management, LLC | +500 | $12.50 | $6,250 | 500 | Nov 14, 2024 |
| Nov 13, 2024 | AVTX Avalo Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Meadowlark Management, LLC | +500 | $13.00 | $6,500 | 1,000 | Nov 14, 2024 |
| Nov 1, 2024 | ATNM Actinium Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.